AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

/PRNewswire/ — ChemLex, a next-generation AI-for-science company, today announced the establishment of its global headquarters and self-driving laboratory in Singapore, alongside the close of a…

West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery

, /PRNewswire/ –West Pharmaceutical Services, Inc.(NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the launch of its West Synchrony™…

Montefiore Einstein and Dandelion Partner to Accelerate AI-Driven Drug Development and New Clinical Care Solutions

, /PRNewswire/ — Montefiore Einstein and Dandelion Health, Inc. (“Dandelion”) have announced a strategic partnership to advance their ability to foster clinical care and drug…

Why investors just bet $85M on this Indian company's generic drug strategy |

, /PRNewswire/ –Community Realty Management, Inc. is providing notice of a recent incident that may affect the privacy of certain individuals’ personal information. While Community…

ARMR Launches up to $30M Capital Raise to Advance Biodefense Platform Against Fentanyl and AI-Driven Synthetic Drug Threats

ARMR is developing pre-exposure biodefense solutions to protect American lives from fentanyl and synthetic drug threats weaponized by U.S. adversaries. Up to $30 million private…

Le nouvel article du C-Path publié dans Nature Reviews Drug Discovery montre comment maximiser l’impact réglementaire des projets menés par des consortiums

, /PRNewswire/ — L’Innovative Health Initiative (IHI) et le Critical Path Institute® (C-Path) annoncent ce jour la publication d’un article révisé par des pairs dans…

Nový článek organizace C-Path v časopise Nature Reviews Drug Discovery ukazuje, jak maximalizovat regulační dopad konsorciálních projektů

, /PRNewswire/ – Iniciativa pro inovativní zdravotnictví (Innovative Health Initiative, IHI) a institut Critical Path Institute® (C-Path) dnes oznámily zveřejnění recenzovaného článku v časopise Nature…

C-Path’s New Paper in Nature Reviews Drug Discovery Highlights How to Maximize the Regulatory Impact of Consortium-Based Projects

, /PRNewswire/ — The Innovative Health Initiative (IHI) and Critical Path Institute® (C-Path) today announced the publication of a peer-reviewed paper in Nature Reviews Drug…

Trump signs order to boost domestic drug manufacturing as pharma tariffs loom

U.S. President Donald Trump speaks before signing executive orders in the Oval Office at the White House, in Washington, D.C., U.S., May 5, 2025. Leah…

Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal

Personalized experiences are becoming increasingly important to customers — and marketers are listening. Just look at Imañya James, a product and marketing specialist for the…